Fluorine‐substituted ligands for the peroxisome proliferator‐activated receptor gamma (Pparγ): Potential imaging agents for metastatic tumors
- 1 May 2001
- journal article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 44 (S1) , S316-S318
- https://doi.org/10.1002/jlcr.25804401111
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The PPARs: From Orphan Receptors to Drug DiscoveryJournal of Medicinal Chemistry, 2000
- Non-thiazolidinedione antihyperglycaemic agents. Part 3: the effects of stereochemistry on the potency of α-methoxy-β-phenylpropanoic acidsBioorganic & Medicinal Chemistry, 1999
- Interdomain communication regulating ligand binding by PPAR-γNature, 1998
- Development of a Scintillation Proximity Assay for Peroxisome Proliferator-Activated Receptor γ Ligand Binding DomainAnalytical Biochemistry, 1998
- Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptorProceedings of the National Academy of Sciences, 1997
- Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγScience, 1996
- PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS: A Nuclear Receptor Signaling Pathway in Lipid PhysiologyAnnual Review of Cell and Developmental Biology, 1996
- Non thiazolidinedione antihyperglycaemic agents. 1: α-Heteroatom substituted β-phenylpropanoic acidsBioorganic & Medicinal Chemistry Letters, 1996
- [[.omega.-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agentsJournal of Medicinal Chemistry, 1994
- An improved [18O]water target for[[18F]fluoride productionThe International Journal of Applied Radiation and Isotopes, 1985